A XXXX in Pakistan.

@entity1 @entity97 @entity1956 @entity3531 @entity409 @entity20332 @entity99
A review of published literature on @entity20332 in Pakistan is presented. A total of 220 abstracts available in the Pakmedinet and Medline have been searched. All relevant articles were reviewed to determine the prevalence of @entity20332 in Pakistan. Two hundred and three (203) relevant articles/abstracts including twenty nine supporting references are included in this review. Of the articles on prevalence of @entity99 , seven were related to @entity99 , fifteen to @entity99 while the remaining articles were on frequency of @entity1956 and C in different disease and healthy population groups. These included eight studies on healthy @entity1 , three on vertical transmission, nineteen on pregnant @entity1 , fifteen on healthy individuals, six on army recruits, thirty one on blood donors, thirteen on health care workers, five on unsafe injections, seventeen on high risk groups, five on @entity1 with provisional diagnosis of @entity99 , thirty three on @entity1 with @entity409 , four on genotypes of @entity97 and five on genotypes of @entity3531 . This review highlights the lack of community-based epidemiological work as the number of subjects studied were predominantly @entity1 , high risk groups and healthy blood donors. High level of @entity99 seroconversion was found in @entity1 and this viral infection accounts for almost 50%-60% of all cases of @entity99 in @entity1 in Pakistan. @entity99 is endemic in the country affecting mostly the adult population and epidemic situations have been reported from many parts of the country. The mean results of HBsAg and Anti-HCV prevalence on the basis of data aggregated from several studies was calculated which shows 2.3% and 2.5% prevalence of HBsAg and Anti-HCV in @entity1 , 2.5% and 5.2% among pregnant @entity1 , 2.6% and 5.3% in general population, 3.5% and 3.1% in army recruits, 2.4% and 3.6% in blood donors, 6.0% and 5.4% in health care workers, 13.0% and 10.3% in high risk groups, 12.3% and 12.0% in @entity1 with provisional diagnosis of @entity99 and 25.7% and 54% in @entity1 with @entity409 respectively. This review has illustrated the high @entity20332 in Pakistan where @entity1956 and C potentially account for a serious burden of the disease. This review has triggered the launching of a network intervention for the @entity99 . This review was used as the basis for the launch of @entity99 programme, but putting it into a formal review took time and the @entity99 program was initiated.
